These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 12801885

  • 1. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats.
    Yamamoto M, Otani M, Jia DM, Fukumitsu K, Yoshikawa H, Akiyama T, Otsuki M.
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885
    [Abstract] [Full Text] [Related]

  • 2. Pancreatic secretion stimulated by CCK is not mediated by capsaicin-sensitive vagal afferent pathway in awake rats.
    Guan D, Phillips WT, Green GM.
    Am J Physiol; 1996 May; 270(5 Pt 1):G881-6. PubMed ID: 8967501
    [Abstract] [Full Text] [Related]

  • 3. Vagally mediated, nonparacrine effects of cholecystokinin-8s on rat pancreatic exocrine secretion.
    Viard E, Zheng Z, Wan S, Travagli RA.
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G493-500. PubMed ID: 17569741
    [Abstract] [Full Text] [Related]

  • 4. The effect of luminal ghrelin on pancreatic enzyme secretion in the rat.
    Nawrot-Porabka K, Jaworek J, Leja-Szpak A, Szklarczyk J, Macko M, Kot M, Mitis-Musioł M, Konturek SJ, Pawlik WW.
    Regul Pept; 2007 Oct 04; 143(1-3):56-63. PubMed ID: 17462749
    [Abstract] [Full Text] [Related]

  • 5. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
    Li Y, Hao Y, Owyang C.
    Am J Physiol; 1997 Sep 04; 273(3 Pt 1):G679-85. PubMed ID: 9316472
    [Abstract] [Full Text] [Related]

  • 6. Endogenous cholecystokinin stimulates pancreatic enzyme secretion via vagal afferent pathway in rats.
    Li Y, Owyang C.
    Gastroenterology; 1994 Aug 04; 107(2):525-31. PubMed ID: 8039628
    [Abstract] [Full Text] [Related]

  • 7. Involvement of vagal nerves in the pancreatostimulatory effects of luminal melatonin, or its precursor L-tryptophan. Study in the rats.
    Nawrot-Porabka K, Jaworek J, Leja-Szpak A, Szklarczyk J, Kot M, Mitis-Musioł M, Konturek SJ, Pawlik WW.
    J Physiol Pharmacol; 2007 Dec 04; 58 Suppl 6():81-95. PubMed ID: 18212402
    [Abstract] [Full Text] [Related]

  • 8. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
    Wan S, Coleman FH, Travagli RA.
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug 04; 293(2):G484-92. PubMed ID: 17569742
    [Abstract] [Full Text] [Related]

  • 9. Pancreatic secretion evoked by cholecystokinin and non-cholecystokinin-dependent duodenal stimuli via vagal afferent fibres in the rat.
    Li Y, Owyang C.
    J Physiol; 1996 Aug 01; 494 ( Pt 3)(Pt 3):773-82. PubMed ID: 8865073
    [Abstract] [Full Text] [Related]

  • 10. Valsartan, a specific angiotensin II receptor blocker, inhibits pancreatic fluid secretion via vagal afferent pathway in conscious rats.
    Yamamoto M, Wei L, Otani M, Harada M, Otsuki M.
    Regul Pept; 2012 Oct 10; 178(1-3):80-5. PubMed ID: 22796317
    [Abstract] [Full Text] [Related]

  • 11. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K, Saito T, Wakatsuki K, Saeki M, Kato T, Kasai H, Kimura K, Fujii M.
    Arzneimittelforschung; 1998 Jan 10; 48(1):52-4. PubMed ID: 9522032
    [Abstract] [Full Text] [Related]

  • 12. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
    Jia D, Taguchi M, Otsuki M.
    Pancreas; 2005 Jan 10; 30(1):54-61. PubMed ID: 15632700
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of intraduodenal infusion of loxiglumide on pancreatic exocrine secretion.
    Tanikawa M, Hayakawa T, Kondo T, Shibata T, Kitagawa M, Kodaira T, Hamaoka T.
    Arzneimittelforschung; 1993 Jan 10; 43(1):35-9. PubMed ID: 8447844
    [Abstract] [Full Text] [Related]

  • 14. Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion.
    Li Y, Owyang C.
    J Clin Invest; 1993 Jul 10; 92(1):418-24. PubMed ID: 8100836
    [Abstract] [Full Text] [Related]

  • 15. The ghrelin pentapeptide inhibits the secretion of pancreatic juice in rats.
    Kapica M, Laubitz D, Puzio I, Jankowska A, Zabielski R.
    J Physiol Pharmacol; 2006 Dec 10; 57(4):691-700. PubMed ID: 17229991
    [Abstract] [Full Text] [Related]

  • 16. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
    Rodriguez AI, Manso MA, Garcia-Montero AC, Orfao A, de Dios I.
    Pancreas; 1997 Oct 10; 15(3):314-22. PubMed ID: 9336798
    [Abstract] [Full Text] [Related]

  • 17. Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats.
    Kanemitsu D, Sakagami J, Motoyoshi T, Nakajima T, Kataoka K.
    Pancreas; 2006 Mar 10; 32(2):190-6. PubMed ID: 16552340
    [Abstract] [Full Text] [Related]

  • 18. Leptin is able to stimulate pancreatic enzyme secretion via activation of duodeno-pancreatic reflex and CCK release.
    Nawrot-Porabka K, Jaworek J, Leja-Szpak A, Palonek M, Szklarczyk J, Konturek SJ, Pawlik WW.
    J Physiol Pharmacol; 2004 Jul 10; 55 Suppl 2():47-57. PubMed ID: 15608360
    [Abstract] [Full Text] [Related]

  • 19. Supramaximal CCK-58 does not induce pancreatitis in the rat: role of pancreatic water secretion.
    Yamamoto M, Reeve JR, Green GM.
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr 10; 292(4):G964-74. PubMed ID: 17158258
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.